56 results
8-K
EX-99.1
CNSP
Cns Pharmaceuticals Inc
12 Apr 24
Regulation FD Disclosure
6:37pm
and long - term business operations and objectives, and financial needs. These forward - looking statements are subject to a number of risks, uncertainties
424B4
CNSP
Cns Pharmaceuticals Inc
31 Jan 24
Prospectus supplement with pricing info
4:27pm
long-term stockholder value will be limited.
Interim or preliminary data from our clinical trials that we announce or publish from time to time may … performance as compared to our expectations and objectives, our desire to motivate our employees to achieve short and long-term results
8-K
EX-99.1
gegr2l
15 Nov 23
Results of Operations and Financial Condition
8:00am
8-K
EX-99.1
qs5lzc oq5q8
14 Aug 23
CNS Pharmaceuticals Reports Second Quarter 2023 Financial Results and Continued rapid pace of enrollment with ~75% of expected patients now enrolled
9:25am
8-K
EX-99.1
i7bc81s
8 May 23
Bettina M. Cockroft, M.D., M.B.A., Pharmaceutical and Biotech Industry Veteran, Joins CNS Pharmaceuticals Board of Directors
8:45am
8-K
EX-99.1
41yyswxcyqsy
10 Jan 22
Regulation FD Disclosure
9:25am
8-K
EX-99.1
37ru4
3 Dec 21
Regulation FD Disclosure
4:08pm
8-K
EX-99.1
8qud99ufhc2pbw hpi
13 Aug 21
CNS Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Outlook
8:10am